SAN FRANCISCO, June 19 - Invitrogen has promoted C. Eric Winzer into the CFO position, the company said today.
Winzer, formerly vice president for finance, takes over from James Glynn, who will remain executive vice president and on the board of directors.
The shuffle is designed to give Glynn more time to focus on mergers and acquisitions, a "major strategy" of the company, an Invitrogen spokesperson told GenomeWeb.
Invitrogen has the cash to do it: At the end of the first quarter 2002, the company reported $694 million in cash and cash equivalents.
Winzer was CFO of Life Technologies prior to the company's acquisition by Invitrogen in 2000.